Centogene(CNTG)
搜索文档
CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency
Newsfilter· 2024-03-01 06:00
研究成果 - CENTOGENE N.V.宣布在Science杂志上发表了关于人类前T细胞受体α（pre-TCRα）缺陷的研究[1] - 研究揭示了完全的pre-TCRα缺陷在人类中很少见，临床表现通常在成年后才出现[2] - CENTOGENE在调查中发挥了关键作用，通过对CENTOGENE生物数据库的深入分析，帮助建立了部分pre-TCRα缺陷与自身免疫疾病之间的关联[3]
CENTOGENE Explores Strategic Alternatives
Newsfilter· 2024-02-28 19:30
公司战略选择 - CENTOGENE宣布决定探索一系列旨在为利益相关者创造可持续长期价值的战略选择[1] 产品创新 - 公司在2023年取得了重大进展，推出了创新和高影响力的基因组和多组学产品[2] 管理层合作评估 - 管理层正在与监事会合作评估可用选项，以确保CENTOGENE处于增长和盈利路径上最佳位置[3]
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
Newsfilter· 2024-01-25 19:30
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Jan. 25, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (NASDAQ:CNTG) (the "Company"), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, and the Laboratory of Human Genetics of Infectious Diseases (the "Lab") at Institut Imagine today announced a strategic research collaboration to improve health outcomes for rare disease patients by accelerating and de-risking drug discovery and clinical development. As part of the ...
CENTOGENE Receives French Research Tax Credit Accreditation
Newsfilter· 2024-01-24 19:30
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (NASDAQ:CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that it has been recognized by the French Ministry of Higher Education and Research as a qualified organization to support partners conducting R&D projects in France. Accordingly, it has received accreditation under the French R&D tax credit initiative ('Crédit d'Impôt Recherche', ...
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson's Disease Using Multiomics
Newsfilter· 2024-01-23 19:30
合作研究项目 - Centogene N.V.与The Michael J. Fox Foundation for Parkinson's Research宣布合作进行研究项目，加速研究与帕金森病相关的GBA基因的遗传风险因素[1] - 该研究项目将利用CENTOGENE在罕见遗传和神经退行性疾病方面的专业知识，利用CENTOGENE生物数据库中的多样性多组学数据，旨在建立对特定GBA基因变异与帕金森病之间关系的更深入理解[2] - 通过与The Michael J. Fox Foundation的合作，CENTOGENE旨在加速研究特定风险因素，以帮助更好地诊断、理解和治疗这种影响全球数百万患者的疾病[4]
Centogene(CNTG) - 2023 Q2 - Quarterly Report
2023-06-30 00:00
Exhibit 99.1 CENTOGENE Announces Approval of All Resolutions Tabled at 2023 Annual General Meeting CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 30, 2023 (GLOBE NEWSWIRE) – CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the voting results of the Company’s Annual General Meeting. Shareholders voted in favor of all proposals, which included the appointment of Prof. Dr. Peter Bauer as a m ...
Centogene(CNTG) - 2022 Q4 - Annual Report
2023-05-16 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal y ear ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1 ...
Centogene (CNTG) presents at H.C. Wainwright 24th Annual Global Investment Conference - Slideshow
2022-09-13 22:16
| --- | --- | --- | --- | |--------------------------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | The Essential Biodata Life Science Partner in | | | | | Rare and | | | | | | | | | | Neurodegenerative Diseases | | | | | H.C. Wainwright 24 th Annual Global Investment Conference | | | | | CENTOGENE NV (NASDAQ: CNTG) September 12, 2022 - New York | | | | | Presenter: Kim Stratton, CEO | | | | Safe Harbour and Disclaimer Statement This presentation has been prepa ...
Centogene(CNTG) - 2021 Q4 - Earnings Call Transcript
2022-03-30 23:48
Call Start: 08:00 January 1, 0000 8:52 AM ET Centogene N.V. (NASDAQ:CNTG) Q4 2021 Earnings Conference Call March 30, 2022, 8:00 AM ET Company Participants Kim Stratton – Chief Executive Officer Miguel Coego Rios – Chief Financial Officer Bettina Goerner – Chief Data Officer Maximilian Schmid – Chief Commercial Officer Lennart Streibel – Investor Relations Conference Call Participants Chad Wiatrowski – SVB Leerink Sung Ji Nam – BTIG Catherine Schulte – Baird Operator Ladies and gentlemen, thank you for stand ...
Centogene(CNTG) - 2021 Q3 - Earnings Call Transcript
2021-11-25 03:45
Centogene N.V. (NASDAQ:CNTG) Q3 2021 Earnings Conference Call November 24, 2021 8:30 AM ET Company Participants Lennart Streibel - Investor Relations Andrin Oswald - Chief Executive Officer Rene Just - Chief Financial Officer Conference Call Participants Puneet Souda - SVB Leerink Catherine Schulte - Baird Sung Ji Nam - BTIG Operator Ladies and gentlemen thank you for standing by and welcome to the CENTOGENE Q3 2021 Earnings Results. At this time, all participants are in a listen-only mode. After the speake ...